Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

E3040

145096-30-6C16H17N3OS299.399 g/mol

A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by a methylnitrilo group, (pyridin-3-yl)methyl group, methyl group, hydroxy group and methyl group at position 2,4,5,6 and 7, respectively. It is a dual inhibitor of 5-lipoxygenase and thromboxane A2 synthetase and exhibits anti-inflammatory properties. The drug was being developed by Eisai (Tokyo, Japan) for the treatment of bowel disease. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number145096-30-6ChEBI ↗
Molecular formulaC16H17N3OSChEBI ↗
Molar mass299.399 g/molChEBI ↗
Monoisotopic mass299.10923 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:4732ChEBI ↗

Cross-source molecular data

PubChem
Molar mass299.4 g/molPubChem ↗
Exact mass299.10923335 DaPubChem ↗
Computed XLogP3.9PubChem ↗
Topological polar surface area (Ų)86.3PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors5PubChem ↗
Rotatable bonds3PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
E3040
5,7-dimethyl-2-(methylamino)-4-(pyridin-3-ylmethyl)-1,3-benzothiazol-6-ol
IONAQTGMWFXHIX-UHFFFAOYSA-N
CNc1nc2c(Cc3cccnc3)c(C)c(O)c(C)c2s1
InChI=1S/C16H17N3OS/c1-9-12(7-11-5-4-6-18-8-11)13-15(10(2)14(9)20)21-16(17-3)19-13/h4-6,8,20H,7H2,1-3H3,(H,17,19)

Names & synonyms

5,7-dimethyl-2-(methylamino)-4-(pyridin-3-ylmethyl)-1,3-benzothiazol-6-ol

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

anti-inflammatory druguricosuric drugEC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00334002 mol

Uses 299.399 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 16 atoms
64.19%
N
Nitrogen · 3 atoms
14.03%
S
Sulfur · 1 atom
10.71%
H
Hydrogen · 17 atoms
5.72%
O
Oxygen · 1 atom
5.34%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:4732

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 443292 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.